Jeffrey Somers - RMR Real Independent Trustee
Executive
Mr. Jeffrey P. Somers is an Independent Trustee of RMR Real Estate Income Fund. He is Of Counsel, Morse, BarnesBrown Pendleton, PC since 2010 Director of Cantella Management Corporationration from 2002 until January 2014, when the company was acquired by a third party Independent Trustee of Senior Housing Properties Trust since 2009 Independent Trustee of Government Properties Income Trust since 2009 Independent Trustee of Select Income REIT since 2012 and Trustee of Pictet Funds . since 2009.
| Age | 76 |
| Tenure | 16 years |
| Phone | 617-332-9530 |
| Web | http://www.rmrfunds.com/funds/fundDetails.aspx?Page=RIF&b=true |
RMR Real Management Efficiency
The company has Return on Asset of 1.46 % which means that on every $100 spent on assets, it made $1.46 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 29.12 %, implying that it generated $29.12 on every 100 dollars invested. RMR Real's management efficiency ratios could be used to measure how well RMR Real manages its routine affairs as well as how well it operates its assets and liabilities.RMR Real Estate has 88 M in debt with debt to equity (D/E) ratio of 0.32, which is OK given its current industry classification. RMR Real Estate has a current ratio of 0.03, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for RMR to invest in growth at high rates of return.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Andrew Murphy | Regeneron Pharmaceuticals | 66 | |
| Ashraf Amanullah | Inhibrx | 57 | |
| David MBA | Inhibrx | N/A | |
| Jessica Gaitan | Fomento Economico Mexicano | N/A | |
| Cara Miller | Tarsus Pharmaceuticals | N/A | |
| Brendan Eckelman | Inhibrx | 46 | |
| Harris Rotman | Centessa Pharmaceuticals PLC | N/A | |
| Patrick MD | Centessa Pharmaceuticals PLC | N/A | |
| Patrice Gilooly | Regeneron Pharmaceuticals | N/A | |
| April Dovholuk | Centessa Pharmaceuticals PLC | N/A | |
| Neera Clase | Tarsus Pharmaceuticals | N/A | |
| MSc MD | Centessa Pharmaceuticals PLC | 66 | |
| Ellie MD | Centessa Pharmaceuticals PLC | N/A | |
| Ian Garca | Fomento Economico Mexicano | 53 | |
| Carlos Bais | Inhibrx | N/A | |
| Scott Youmans | Tarsus Pharmaceuticals | N/A | |
| Martin Yaniz | Fomento Economico Mexicano | N/A | |
| Bonne MBA | Inhibrx | 48 | |
| Melissa Lozner | Regeneron Pharmaceuticals | N/A | |
| Ryan Crowe | Regeneron Pharmaceuticals | N/A | |
| Josep Garcia | Inhibrx | N/A | |
Management Performance
| Return On Equity | 29.12 | |||
| Return On Asset | 1.46 |
RMR Real Estate Leadership Team
Elected by the shareholders, the RMR Real's board of directors comprises two types of representatives: RMR Real inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RMR. The board's role is to monitor RMR Real's management team and ensure that shareholders' interests are well served. RMR Real's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RMR Real's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jennifer Clark, Secretary, Chief Legal Officer and Managing Trustee | ||
| Adam Portnoy, President, Chief Executive Officer, Trustee | ||
| Barbara Gilmore, Independent Trustee | ||
| Vern Larkin, Chief Compliance Officer and Director of Internal Audit | ||
| Brian Donley, Chief Financial Officer, Treasurer, Assistant Secretary | ||
| John Harrington, Independent Trustee | ||
| Fernando Diaz, President, Senior Portfolio Manager | ||
| Jeffrey Somers, Independent Trustee |
RMR Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is RMR Real a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 29.12 | |||
| Return On Asset | 1.46 | |||
| Profit Margin | 598.80 % | |||
| Operating Margin | 65.58 % | |||
| Current Valuation | 226.09 M | |||
| Shares Outstanding | 10.2 M | |||
| Shares Owned By Insiders | 11.04 % | |||
| Shares Owned By Institutions | 29.64 % | |||
| Price To Earning | 1.73 X | |||
| Price To Book | 0.48 X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in RMR Stock
If you are still planning to invest in RMR Real Estate check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RMR Real's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |